Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Untch

Showing results (101-110 of 377) with videos related to

Pageof 38
Sort By:
International Journal of Cancer|October 12, 2013
Monounsaturated fatty acids in serum triacylglycerols are associated with response to neoadjuvant chemotherapy in breast cancer patientsMika Hilvo, Stephan Gade, Tuulia Hyötyläinen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2024
Disease-free survival as a surrogate for overall survival in HR+/HER2- early breast cancer: A correlation analysisMichael Untch, David Pérol, Erica L Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsiesAnnette Lebeau, Andreas Turzynski, Susanne Braun, et al.
Breast Cancer Research and Treatment|August 4, 2014
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trialVolkmar Müller, Stephan Gade, Bettina Steinbach, et al.
The Lancet. Oncology|May 21, 2013
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort studyThorsten Kuehn, Ingo Bauerfeind, Tanja Fehm, et al.
Journal of the National Cancer Institute|July 18, 2013
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trialVolker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Cancers|July 29, 2023
Elderly and Patients with Large Breast Volume Have an Increased Risk of Seroma Formation after Mastectomy-Results of the SerMa Pilot StudyMelitta Beatrice Köpke, Carl Mathis Wild, Mariella Schneider, et al.
Breast (Edinburgh, Scotland)|January 8, 2017
pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trialsMattea Reinisch, Jens Huober, Gunter von Minckwitz, et al.
Breast Care (Basel, Switzerland)|May 4, 2012
ABC1 Consensus Conference - a German Perspective: First International Consensus Conference on Advanced Breast Cancer (ABC1), Lisbon, November 5, 2011Christoph Thomssen, Norbert Marschner, Michael Untch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" TrialSabine Riethdorf, Volkmar Müller, Sibylle Loibl, et al.
Pageof 38

Showing results (101-110 of 377) with videos related to

Sort By:
Pageof 38
International Journal of Cancer|October 12, 2013
Monounsaturated fatty acids in serum triacylglycerols are associated with response to neoadjuvant chemotherapy in breast cancer patientsMika Hilvo, Stephan Gade, Tuulia Hyötyläinen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2024
Disease-free survival as a surrogate for overall survival in HR+/HER2- early breast cancer: A correlation analysisMichael Untch, David Pérol, Erica L Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsiesAnnette Lebeau, Andreas Turzynski, Susanne Braun, et al.
Breast Cancer Research and Treatment|August 4, 2014
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trialVolkmar Müller, Stephan Gade, Bettina Steinbach, et al.
The Lancet. Oncology|May 21, 2013
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort studyThorsten Kuehn, Ingo Bauerfeind, Tanja Fehm, et al.
Journal of the National Cancer Institute|July 18, 2013
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trialVolker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Cancers|July 29, 2023
Elderly and Patients with Large Breast Volume Have an Increased Risk of Seroma Formation after Mastectomy-Results of the SerMa Pilot StudyMelitta Beatrice Köpke, Carl Mathis Wild, Mariella Schneider, et al.
Breast (Edinburgh, Scotland)|January 8, 2017
pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trialsMattea Reinisch, Jens Huober, Gunter von Minckwitz, et al.
Breast Care (Basel, Switzerland)|May 4, 2012
ABC1 Consensus Conference - a German Perspective: First International Consensus Conference on Advanced Breast Cancer (ABC1), Lisbon, November 5, 2011Christoph Thomssen, Norbert Marschner, Michael Untch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" TrialSabine Riethdorf, Volkmar Müller, Sibylle Loibl, et al.
Pageof 38